Join us on Wednesday, November 8th in the Goldman International Conference Center B for an ePanel live presentation titled “Rigor in Science: The Challenge of Reproducibility in Biomedical Research.”
The goal of this discussion is to explore both the tensions and opportunities for exciting science that irreproducible results create in preclinical research. It also considers economical ways for researchers to address biological drivers of irreproducible results, to comply with new standards set out by funding agencies, and to enhance the potential of their work to lead to novel therapies.
This discussion will include the following panelists: Investigators Michael Holtzman, Dana Philpott, Jeffrey Haspel, and Patricia Valdez, and NPR Science Correspondent Richard Harris will moderate the discussion.
The post Rigor in Science: The Challenge of Reproducibility in Biomedical Research appeared first on The Feinstein Institute for Medical Research.